1.Establishment of Drug Risk Management System -the Promise of Safety Science Approaching from Non-Clinical Safety
Ichiro TSUNENARI ; Kyoko BARATA ; Naoki NAKAYAMA ; Shoichiro SUGAI ; Motomu TAN ; Shoji SASAKI ; Takashi UNNO ; Kazuhiko MATSUMOTO
Japanese Journal of Pharmacoepidemiology 2008;13(1):29-38
A questionnaire survey of risk management systems for medical products was conducted with the cooperation of domestic and foreign pharmaceutical companies. As for the foreign companies, it was revealed that specialized safety management teams and data-management committees are established to formulate risk management plans in order to create systems that assure consistent risk management for each company. In addition, it was revealed that toxicologists are incorporated in the central decision making organization. As for domestic companies, it turned out that no less than half of the respondents pay attention to consistent risk management from the development stage through the post marketing stage. From now on, it will be essential to consolidate safety data, improve the accessibility of centralized safety data from the relevant departments, and establish systems to provide consistent risk management from the development stage to the post marketing stage.
2.A novel mechanism of bitter taste transduction.
Akimichi KANEKO ; Hiroko TAKEUCHI ; Takashi KURAHASHI ; Takashi TSUNENARI
The Korean Journal of Physiology and Pharmacology 1999;3(5):455-459
Bitter taste is an important warning sign for animals that food is poisonous. The transduction mechanism of bitter taste is still a contradictory matter among researchers. The major current hypothesis, based mainly on biochemical data, involves metabotropic cascades, either via cytoplasmic cyclic nucleotide monophosphate (cNMP) or via IP3. The former hypothesis involves cytoplasmic cNMP. It has been shown that a taste receptor cell expresses a specific G protein (McLaughlin et al, 1992) that activates phosphodiesterase leading to the decomposition of cNMP (Price, 1973; Ruiz-Avila et al, 1995). The frog taste receptor cell has a cationic channel, which is kept closed at a high cNMP concentration. Bitter stimuli reduce the cNMP concentration and release the cationic channel from the closed state (Kolesnikov & Margolskee, 1995). The latter hypothesis involves the cytoplasmic inositol 1,4,5-trisphosphate (IP3) as a second messenger. This hypothesis proposes that a bitter substance increases the cytoplasmic IP3 concentration by activating a G protein and phospholipase C. IP3 triggers Ca2+ release from the endoplasmic reticulum, which in turn directly or indirectly induces transmitter release from the taste receptor cells (Akabas et al, 1988; Hwang et al, 1990; Spielman et al, 1994, Spielman et al, 1996). We found recently an entirely different mechanism for the bitter taste transduction. We excised a patch membrane from an isolated taste receptor cell of the fungiform papillae of the bullfrog (Tsunenari et al, 1996, 1999) and recorded in the outside-out configuration. The patch pipette was filled with a solution containing 120 mM CsCl, 2 mM Na2-EGTA and 10 mM Na-HEPES. The outside of the patch membrane was exposed to the 120 mM NaCl solution containing 120 mM NaCl and 2 mM Na-HEPES. Thus, on the cytoplasmic face of the patch membrane none of the second messenger candidates or their precursors (eg. cyclic nucleotide, IP3, Ca2+, ATP and GTP) was present.
Adenosine Triphosphate
;
Animals
;
Cytoplasm
;
Endoplasmic Reticulum
;
GTP-Binding Proteins
;
Inositol 1,4,5-Trisphosphate
;
Membranes
;
Rana catesbeiana
;
Second Messenger Systems
;
Type C Phospholipases